Allergen Extract Market Research
ID: PANHCA-25-005782Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M MRCO EASTFORT BELVOIR, VA, 22060-5580, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/e066894096514d7fb8c9da30fd124025/view
Timeline
    Description

    The Department of Defense, specifically the Department of the Army, is seeking information from manufacturers and distributors regarding allergen extracts as part of a sources sought notice. The objective is to gain insights into the market for these extracts, particularly identifying which products respondents manufacture or distribute, and to encourage the submission of any unique FDA licenses or patents related to the desired allergen extracts listed in the accompanying document. This initiative is crucial for supporting research and diagnostic applications in public health, as the detailed listing of biological materials includes various concentrations and formulations relevant for scientific study. Interested parties should reach out to Jessie G. Hart at jessie.g.hart.civ@health.mil or Ricardo Cordero Cruz at ricardo.a.corderocruz.civ@health.mil for further information, with a future solicitation expected to be announced on sam.gov.

    Point(s) of Contact
    Jessie G. hart
    jessie.g.hart.civ@health.mil
    Ricardo Cordero Cruz
    ricardo.a.corderocruz.civ@health.mil
    Files
    Title
    Posted
    Allergen Extract Listing for RFI 1-3-2025.xlsx
    The document details a comprehensive list of biological materials, highlighting their concentrations and formulations, primarily for research and diagnostic uses. The items are categorized into groups such as epithelia, feathers, fungi, plants, nuts, and various food products, with specific volumetric concentrations noted, often indicated as "W/V" or "BAU" alongside a glycerinated formulation. The file is structured methodically, making it easy to identify specific types of organisms or food products and their corresponding details, such as “1:20 W/V 50% Glycerinated” for many entries. The primary purpose appears to be informing potential federal and state researchers or grant applicants about the types of biological materials they can work with, relevant concentrations, and availability for study or application in various scientific contexts. This aligns with typical government Requests for Proposals (RFPs) and grants intended for biological research initiatives or public health undertakings. The information serves as an essential resource for laboratory settings and provides foundational data for applicants pursuing related grants or projects, underscoring the relevance of biological diversity in scientific research.
    Lifecycle
    Title
    Type
    Allergen Extract Market Research
    Currently viewing
    Sources Sought
    Similar Opportunities
    Fexofenadine HCL Follow On MOD P00002
    Active
    Dept Of Defense
    Special Notice: DEPT OF DEFENSE - DEFENSE LOGISTICS AGENCY is seeking Fexofenadine HCL Follow On MOD P00001. Fexofenadine HCL is a drug used to relieve symptoms of seasonal allergies such as runny nose, sneezing, itchy or watery eyes, and itching of the nose or throat. This procurement is for NDC changes. For more information, please contact Catherine Gilbert at catherine.gilbert@dla.mil or 2157374778.
    Biotin Molecules
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking suppliers for various biotin molecules through a combined synopsis/solicitation. The procurement includes specific biotin products such as B-100-B a-Bungarotoxin-Biotin, STC-460-B Chlorotoxin-Biotin, STS-400-B Stichodactyla Toxin-Biotin, and STC-666-B Conantokin G-Biotin, each in 50ug quantities. These biotin molecules are essential for various analytical and laboratory applications, contributing to research and development in biochemical fields. Interested vendors can reach out to Carl Lundell at carl.lundell@westpoint.edu or call 845.938.8298 for further details regarding the procurement process.
    Fexofenadine HCL Follow On
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY is procuring Fexofenadine HCL Follow On. Fexofenadine HCL is typically used as an antihistamine to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching.
    Sources Sought Notice for Chemiluminescent immunoassay (CLIA) kits compatible with the government’s current CLIA instrumentation for the Brooke Army Medical Center (BAMC).
    Active
    Dept Of Defense
    The Department of Defense, through the Medical Readiness Contracting Office West (MRCO), is seeking potential sources to provide Chemiluminescent immunoassay (CLIA) kits compatible with the existing CLIA instrumentation at the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement aims to secure FDA-approved assay kits that meet specific testing requirements, including rapid turnaround times and comprehensive training for laboratory staff. This initiative is crucial for maintaining efficient laboratory services and public health monitoring, as it supports a range of immunological tests essential for patient care. Interested vendors are encouraged to submit their capability statements and relevant information to the primary contact, Medina L. Woodson, at medina.l.woodson.civ@health.mil by the specified deadline, with a base performance period anticipated from October 1, 2025, to September 30, 2030.
    6505--762-25-1-040-0284 -Tucson CMOP FEXOFENADINE -(VA-25-00020806)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Fexofenadine HCL 60MG (500CT) for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). Vendors are required to submit detailed quotes that include a signed SF1449 solicitation cover page, a completed pricing schedule, a valid wholesale distributor license, and OEM authorization for over-the-counter products, ensuring compliance with the Buy American Act and other regulatory standards. This pharmaceutical product is critical for treating allergies and must meet stringent quality and safety requirements, including a minimum shelf life of one year upon delivery. Proposals are due by January 10, 2025, at 3:00 PM CT, and interested vendors can contact Contract Specialist Jennifer D Coleman at jennifer.coleman4@va.gov for further information.
    FDA Regulated Products Sampling Services
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Sampling Services for FDA-regulated products through a Sources Sought Notice (Ref No. 75F40125R00032). The primary objective of this procurement is to identify capable businesses that can collect physical samples of food, drugs, medical devices, and other products for laboratory analysis, ensuring safety and verifying labeling accuracy. This initiative is crucial for the FDA's regulatory oversight, as it supports the monitoring of product safety and quality, which may include both domestic and imported goods. Interested parties must submit their responses by January 9, 2025, and can contact Amanda Lusk at Amanda.Lusk@fda.hhs.gov or Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov for further information.
    REQUEST FOR INFORMATION METABOLOMICS ANALYSIS SERVICES
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is seeking information from qualified vendors for specialized metabolomics analysis services to support ongoing research at the United States Army Medical Research Institute of Environmental Medicine (USARIEM). The procurement aims to obtain both untargeted and targeted metabolomics measurements from various human biological samples, including urine, blood, feces, saliva, and tissue, necessitating advanced laboratory capabilities such as ultra-high performance liquid chromatography-tandem-mass spectrometry (UPLC-MS/MS) and gas chromatography-mass spectrometry (GC-MS). This initiative is critical for enhancing the understanding of metabolic functions and nutritional status within military health studies. Interested parties must submit their qualifications, including business size and capabilities, by January 7, 2025, to Kasey Carroll at kasey.l.carroll.civ@health.mil, as responses are voluntary and will not result in a binding contract.
    Doxycycline Hyclate
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Doxycycline Hyclate. The contract will establish a national supply source to provide Doxycycline Hyclate 100MG Tablets in various bottle sizes. This acquisition is for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The contract will be firm-fixed price, requirements type with a one year base and four one year options. Interested parties should contact Catherine Gilbert for more information. The projected solicitation date is September 2019.
    Sources Sought - Testing Kit, Petroleum; NSN: 6630-01-165-7133
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army Contracting Command - Detroit Arsenal (ACC-DTA), is seeking information from businesses regarding the production of a Testing Kit for Petroleum, identified by NSN 6630-01-165-7133. This Sources Sought Notice aims to gather insights on the capabilities and qualifications of potential suppliers, with an initial requirement for 28 units and an option for an additional 28 units. The testing kit is crucial for ensuring the quality and safety of petroleum products, and the government is looking to assess market capabilities to inform future acquisition strategies. Interested parties must submit their responses, including company profiles and manufacturing capabilities, by January 16, 2025, to Diana Jones at diana.jones47.civ@army.mil, with all submissions being voluntary and unsolicited.
    National Institute of Environmental Health Sciences (NIEHS) Assessment of Immunotoxicity – In Vitro and In Vivo Assessment of Immune Function
    Active
    Health And Human Services, Department Of
    The National Institute of Environmental Health Sciences (NIEHS), part of the Department of Health and Human Services, is seeking proposals for a federal contract focused on the assessment of immunotoxicity through in vitro and in vivo evaluation of immune function. The objective is to provide comprehensive research services to evaluate how selected test agents may modulate immune responses, utilizing both established and innovative methodologies to reduce animal use in toxicology studies. This contract, anticipated to be a cost-plus-fixed-fee type, is expected to be awarded by September 2025, with a base period of one year and nine optional one-year extensions. Interested parties should direct inquiries to Adam Muhsin at adam.muhsin@nih.gov and monitor the Sam.gov website for the solicitation release, which is expected no sooner than 15 days from this notice.